{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:16:05Z","timestamp":1789665365069,"version":"4.0.1"},"reference-count":65,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Bialystok"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Psoriasis is a complex, chronic, immunologically mediated disease which involves skin and joints. Psoriasis is commonly connected with numerous other diseases such as liver diseases, metabolic syndrome, impaired glucose tolerance, diabetes mellitus, atherosclerosis, hypertension, and ischemic heart disease. Interestingly, comorbidities of psoriasis are an attention-grabbing issue. Additionally, it can cause impairment of quality of life and may be associated with depressive disorders. Altered levels of ceramides in psoriatic skin may lead to anti-apoptotic and pro-proliferative states, consequently leading to an over-proliferation of keratinocytes and the development of skin lesions. The pathophysiology of psoriasis and its comorbidities is not fully understood yet. Sphingolipids (including ceramides) and their disturbed metabolism may be the link between psoriasis and its comorbidities. Overall, the goal of this review was to discuss the role of sphingolipid disturbances in psoriasis and its comorbidities. We searched the PubMed database for relevant articles published before the beginning of May 2022. The systematic review included 65 eligible original articles.<\/jats:p>","DOI":"10.3390\/metabo12121171","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T04:34:52Z","timestamp":1669264492000},"page":"1171","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Role of Sphingolipids in the Pathogenesis of Psoriasis"],"prefix":"10.3390","volume":"12","author":[{"given":"Mateusz","family":"Matwiejuk","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Mysliwiec","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Chabowski","sequence":"additional","affiliation":[{"name":"Department of Physiology, Medical University of Bialystok, 15-222 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Flisiak","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"714","DOI":"10.5114\/ada.2019.91422","article-title":"Serum sphingolipid level in psoriatic patients with obesity","volume":"36","author":"Milewska","year":"2019","journal-title":"Adv. Dermatol. Allergol."},{"key":"ref_3","first-page":"108397","article-title":"Lipidomic Analysis Reveals Specific Differences between Fibroblast and Keratinocyte Ceramide Profile of Patients with Psoriasis Vulgaris Molecules","volume":"214","author":"Domingues","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00403-017-1748-x","article-title":"Serum fatty acid profile in psoriasis and its comorbidity","volume":"309","author":"Baran","year":"2017","journal-title":"Arch. Dermatol. Res."},{"key":"ref_5","unstructured":"Checa, A., Xu, N., Sar, D.G., Haeggstr\u00f6m, J.Z., St\u00e5hle, M., and Wheelock, C.E. (2019). Circulating levels of sphingosine-1-phosphate are elevated in severe, but not mild psoriasis and are unresponsive to anti-TNF-\u03b1 treatment. PLoS ONE, 14."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1194\/jlr.RA119000254","article-title":"Inhibition of sphingosine 1-phosphate lyase activates human keratinocyte differentiation and attenuates psoriasis in mice","volume":"61","author":"Jeon","year":"2020","journal-title":"J. Lipid Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3346\/jkms.2006.21.1.95","article-title":"Ceramides and Cell Signaling Molecules in Psoriatic Epidermis: Reduced Levels of Ceramides, PKC-\u03b1, and JNK","volume":"21","author":"Lew","year":"2006","journal-title":"J. Korean Med. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Yokose, U., Ishikawa, J., Morokuma, Y., Naoe, A., Inoue, Y., Yasuda, Y., Tsujimura, H., Fujimura, T., Murase, T., and Hatamochi, A. (2020). The ceramide [NP]\/[NS] ratio in the stratum corneum is a potential marker for skin properties and epidermal differentiation. BMC Dermatol., 20.","DOI":"10.1186\/s12895-020-00102-1"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/jcp.21784","article-title":"Retinoid-responsive transcriptional changes in epidermal keratinocytes","volume":"220","author":"Lee","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.0022-202X.2004.23469.x","article-title":"Alterations of Glucosylceramide-\u03b2-Glucosidase Levels in the Skin of Patients with Psoriasis Vulgaris","volume":"123","author":"Alessandrini","year":"2004","journal-title":"J. Investig. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Moskot, M., Boche\u0144ska, K., Jak\u00f3bkiewicz-Banecka, J., Banecki, B., and Gabig-Cimi\u0144ska, M. (2018). Abnormal Sphingolipid World in Inflammation Specific for Lysosomal Storage Diseases and Skin Disorders. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010247"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.jid.2018.02.003","article-title":"Bioactive Lipid Mediator Profiles in Human Psoriasis Skin and Blood","volume":"138","author":"Sorokin","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1248\/bpb.b17-00939","article-title":"Validating a Selective S1P1 Receptor Modulator Syl930 for Psoriasis Treatment","volume":"41","author":"Ji","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/jid.2008.66","article-title":"K6PC-5, a Direct Activator of Sphingosine Kinase 1, Promotes Epidermal Differentiation Through Intracellular Ca2+ Signaling","volume":"128","author":"Hong","year":"2008","journal-title":"J. Investig. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/eji.201948349","article-title":"S1PR4-dependent CCL2 production promotes macrophage recruitment in a murine psoriasis model","volume":"50","author":"Schuster","year":"2020","journal-title":"Eur. J. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.clinthera.2021.06.008","article-title":"Risk of Thromboembolic Events and Associated Risk Factors, Including Treatments, in Patients with Immune-mediated Diseases","volume":"43","author":"Setyawan","year":"2021","journal-title":"Clin. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jtcme.2021.06.007","article-title":"The therapeutic effects of Bombyx mori sericin on rat skin psoriasis through modulated epidermal immunity and attenuated cell proliferation","volume":"11","author":"Rujimongkon","year":"2021","journal-title":"J. Tradit. Complement. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jdermsci.2021.04.004","article-title":"Fingolimod ameliorates imiquimod-induced psoriasiform dermatitis by sequestrating interleukin-17-producing ?d T cells in secondary lymph nodes","volume":"102","author":"Okura","year":"2021","journal-title":"J. Dermatol. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Shin, S.-H., Kim, H.-Y., Yoon, H.-S., Park, W.-J., Adams, D., Pyne, N., Pyne, S., and Park, J.-W. (2020). A Novel Selective Sphingosine Kinase 2 Inhibitor, HWG-35D, Ameliorates the Severity of Imiquimod-Induced Psoriasis Model by Blocking Th17 Differentiation of Na\u00efve CD4 T Lymphocytes. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218371"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Boche\u0144ska, K., Moskot, M., Malinowska, M., Jak\u00f3bkiewicz-Banecka, J., Szczerkowska-Dobosz, A., Purzycka-Bohdan, D., Ple\u0144kowska, J., S\u0142omi\u0144ski, B., and Gabig-Cimi\u0144ska, M. (2019). Lysosome Alterations in the Human Epithelial Cell Line HaCaT and Skin Specimens: Relevance to Psoriasis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092255"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e151911","DOI":"10.1172\/jci.insight.151911","article-title":"Phospholipase A2 enzymes represent a shared pathogenic pathway in psoriasis and pityriasis rubra pilaris","volume":"6","author":"Shao","year":"2021","journal-title":"JCI Insight"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"95931","DOI":"10.18632\/oncotarget.21562","article-title":"Untargeted serum metabonomics study of psoriasis vulgaris based on ultra-performance liquid chromatography coupled to mass spectrometry","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s00403-005-0551-2","article-title":"Ceramide profiles of the uninvolved skin in atopic dermatitis and psoriasis are comparable to those of healthy skin","volume":"296","author":"Farwanah","year":"2005","journal-title":"Arch. Dermatol. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.5021\/ad.2013.25.3.321","article-title":"Altered Levels of Sphingosine and Sphinganine in Psoriatic Epidermis","volume":"25","author":"Moon","year":"2013","journal-title":"Ann. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"\u0141uczaj, W., Dobrzy\u0144ska, I., Wro\u0144ski, A., Domingues, M.R., Domingues, P., and Skrzydlewska, E. (2020). Cannabidiol-Mediated Changes to the Phospholipid Profile of UVB-Irradiated Keratinocytes from Psoriatic Patients. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186592"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/gigascience\/gix087","article-title":"Lipidomics profiling reveals the role of glycerophospholipid metabolism in psoriasis","volume":"6","author":"Zeng","year":"2017","journal-title":"GigaScience"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kim, D., Kim, H.-J., Baek, J.-O., Roh, J.-Y., and Jun, H.-S. (2021). Lysophosphatidic Acid Mediates Imiquimod-Induced Psoriasis-like Symptoms by Promoting Keratinocyte Proliferation through LPAR1\/ROCK2\/PI3K\/AKT Signaling Pathway. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910777"},{"key":"ref_30","first-page":"15280","article-title":"Characterization of the abnormal lipid profile in Chinese patients with psoriasis","volume":"8","author":"Pang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2133.2011.10539.x","article-title":"Correlation between lipoprotein(a) and lipid peroxidation in psoriasis: Role of the enzyme paraoxonase-1","volume":"166","author":"Ferretti","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"100094","DOI":"10.1016\/j.jlr.2021.100094","article-title":"Lipidomic and transcriptional analysis of the linoleoyl-omega-hydroxyceramide biosynthetic pathway in human psoriatic lesions","volume":"62","author":"Tyrrell","year":"2021","journal-title":"J. Lipid Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"15602","DOI":"10.1074\/jbc.M116.734657","article-title":"Expression and Function of Group IIE Phospholipase A2 in Mouse Skin","volume":"291","author":"Yamamoto","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Gaire, B.P., Lee, C.-H., Kim, W., Sapkota, A., Lee, D.Y., and Choi, J.W. (2020). Lysophosphatidic Acid Receptor 5 Contributes to Imiquimod-Induced Psoriasis-Like Lesions through NLRP3 Inflammasome Activation in Macrophages. Cells, 9.","DOI":"10.3390\/cells9081753"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Syed, S.N., Weigert, A., and Br\u00fcne, B. (2020). Sphingosine Kinases are Involved in Macrophage NLRP3 Inflammasome Transcriptional Induction. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21134733"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/jid.2010.342","article-title":"Epidermal FABP (FABP5) Regulates Keratinocyte Differentiation by 13(S)-HODE-Mediated Activation of the NF-\u03baB Signaling Pathway","volume":"131","author":"Ogawa","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-021-04284-5","article-title":"Inhibition of keratinocyte ferroptosis suppresses psoriatic inflammation","volume":"12","author":"Shou","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_38","first-page":"107","article-title":"Epidermal sphingolipids: Metabolism, function, and roles in skin disorders","volume":"4","author":"Holleran","year":"2003","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-021-02715-4","article-title":"The difference of lipid profiles between psoriasis with arthritis and psoriasis without arthritis and sex-specific downregulation of methotrexate on the apolipoprotein B\/apolipoprotein A-1 ratio","volume":"24","author":"Wang","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.5114\/aoms.2019.89451","article-title":"Abnormal serum fatty acid profile in psoriatic arthritis","volume":"15","author":"Baran","year":"2019","journal-title":"Arch. Med. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/annrheumdis-2019-216374","article-title":"Differences in the serum metabolome and lipidome identify potential biomarkers for seronegative rheumatoid arthritis versus psoriatic arthritis","volume":"79","author":"Behnisch","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1177\/1535370221993424","article-title":"Inhibition of phospholipases suppresses progression of psoriasis through modulation of inflammation","volume":"246","author":"Gao","year":"2021","journal-title":"Exp. Biol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/jid.2013.364","article-title":"Interferon-\u03b3 Decreases Ceramides with Long-Chain Fatty Acids: Possible Involvement in Atopic Dermatitis and Psoriasis","volume":"134","author":"Tawada","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jid.2019.09.011","article-title":"Homeostatic Function of Dermokine in the Skin Barrier and Inflammation","volume":"140","author":"Utsunomiya","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_45","first-page":"18","article-title":"Ceramide- and Keratolytic-containing Body Cleanser and Cream Application in Patients with Psoriasis: Outcomes from a Consumer Usage Study","volume":"12","year":"2019","journal-title":"J. Clin. Aesthetic Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00128071-200506040-00002","article-title":"Role of Ceramides in Barrier Function of Healthy and Diseased Skin","volume":"6","author":"Choi","year":"2005","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/archderm.1994.01690040056007","article-title":"Abnormality of Water Barrier Function in Psoriasis. Role of ceramide fractions","volume":"130","author":"Motta","year":"1994","journal-title":"Arch. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3346\/jkms.2004.19.6.859","article-title":"An Inverse Relationship Between Ceramide Synthesis and Clinical Severity in Patients with Psoriasis","volume":"19","author":"Cho","year":"2004","journal-title":"J. Korean Med. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejpb.2018.02.037","article-title":"Delivery of oat-derived phytoceramides into the stratum corneum of the skin using nanocarriers: Formulation, characterization and in vitro and ex-vivo penetration studies","volume":"127","author":"Tessema","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/exd.14068","article-title":"The importance of caveolins and caveolae to dermatology: Lessons from the caves and beyond","volume":"29","author":"Egger","year":"2019","journal-title":"Exp. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0014-5793(95)01421-7","article-title":"The vitamin D3analogue, calcipotriol, induces sphingomyelin hydrolysis in human keratinocytes","volume":"378","author":"Geilen","year":"1996","journal-title":"FEBS Lett."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41591-018-0003-0","article-title":"Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasis","volume":"24","author":"Zhang","year":"2018","journal-title":"Nat. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e14263","DOI":"10.1111\/dth.14263","article-title":"Efficacy and safety of a topical moisturizer containing linoleic acid and ceramide for mild-to-moderate psoriasis vulgaris: A multicenter randomized controlled trial","volume":"33","author":"Li","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Liu, F., Wang, S., Liu, B., Wang, Y., and Tan, W. (2020). (R)-Salbutamol Improves Imiquimod-Induced Psoriasis-Like Skin Dermatitis by Regulating the Th17\/Tregs Balance and Glycerophospholipid Metabolism. Cells, 9.","DOI":"10.3390\/cells9020511"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2249.2012.04625.x","article-title":"Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: Are we close to reality?","volume":"171","author":"Simoni","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"ref_56","first-page":"441","article-title":"The role of sphingolipid metabolism in cutaneous permeabilitybarrier formation","volume":"1841","author":"Breiden","year":"2014","journal-title":"Biochim. et Biophys. Acta (BBA)-Mol. Cell Biol. Lipids"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3346\/jkms.2007.22.5.862","article-title":"A Study on Altered Expression of Serine Palmitoyltransferase and Ceramidase in Psoriatic Skin Lesion","volume":"22","author":"Hong","year":"2007","journal-title":"J. Korean Med. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"310","DOI":"10.5114\/ada.2021.106209","article-title":"Lipid profile disturbances may predispose psoriatic patients to liver dysfunction","volume":"38","author":"Milewska","year":"2021","journal-title":"Adv. Dermatol. Allergol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s12020-011-9589-4","article-title":"Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome","volume":"41","author":"Majumdar","year":"2012","journal-title":"Endocrine"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/CIRCULATIONAHA.119.041882","article-title":"Altering Sphingolipid Metabolism Attenuates Cell Death and Inflammatory Response After Myocardial Infarction","volume":"141","author":"Hadas","year":"2020","journal-title":"Circulation"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI131838","article-title":"Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease","volume":"130","author":"Poss","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Kovilakath, A., Jamil, M., and Cowart, L.A. (2020). Sphingolipids in the Heart: From Cradle to Grave. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00652"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"574","DOI":"10.5543\/tkda.2012.54920","article-title":"Determination of subclinical atherosclerosis in plaque type psoriasis patients without traditional risk factors for atherosclerosis","volume":"40","author":"Altekin","year":"2012","journal-title":"Turk Kardiyol. Dern. Ars."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.3906\/sag-2101-137","article-title":"A novel marker of systemic inflammation in psoriasis and related comorbidities: Chitotriosidase","volume":"51","author":"Ilanbey","year":"2021","journal-title":"Turk. J. Med. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s40264-021-01057-z","article-title":"Safety of S1P Modulators in Patients with Immune-Mediated Diseases: A Systematic Review and Meta-Analysis","volume":"44","author":"Lasa","year":"2021","journal-title":"Drug Saf."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/12\/12\/1171\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:25:53Z","timestamp":1760145953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/12\/12\/1171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,24]]},"references-count":65,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["metabo12121171"],"URL":"https:\/\/doi.org\/10.3390\/metabo12121171","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,24]]}}}